IP Library Granted Patent US 6,852,484
Granted Patent B2
US 6,852,484 · App. 10/012,991 · Granted Feb 8, 2005

Methods for the identification of inhibitors of asparagine synthase as antibiotics

Assignee: Icoria, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,852,484
App. No.
10/012,991
Granted
Feb 8, 2005
Kind
B2
Abstract

The present inventors have discovered that Asparagine Synthase is essential for fungal pathogenicity. Specifically, the inhibition of Asparagine Synthase gene expression in fungi results in no signs of successful infection or lesions. Thus, Asparagine Synthase can be used as a target for the identification of antibiotics, preferably antifungals. Accordingly, the present invention provides methods for the identification of compounds that inhibit Asparagine Synthase expression or activity. The methods of the invention are useful for the identification of antibiotics, preferably antifungals.

Claims (12)

1. A method for identifying a test compound as a candidate for an antibiotic, comprising:

a) contacting L-aspartate, L-glutamine, and ATP with a filamentous fungal Asparagine Synthase;

b) contacting L-aspartate, L-glutamine, and ATP with the filamentous fungal Asparagine synthase and a test compound; and

c) determining the change in concentration for at least one of the following: L-aspartate, L-glutamine, L-asparagine, L-glutamate, ATP, AMP, and/or pyrophosphate, wherein a change in concentration for any of the above substances between steps (a) and (b) indicates that the test compound is a candidate for an antibiotic.

2. The method of claim 1 , wherein the Asparagine Synthase is a Magnaporthe grisea Asparagine Synthase.

3. The method of claim 1 , wherein the Asparagine Synthase is SEQ ID NO: 3.

4. A method for identifying a test compound as a candidate for an antibiotic, comprising:

a) contacting L-asparagine, L-glutamate, AMP, and pyrophosphate with a filamentous fungal Asparagine Synthase;

b) contacting L-asparagine, L-glutamate, AMP, and pyrophosphate with the filamentous fungal Asparagine Synthase and a test compound; and

c) determining the change in concentration for at least one of the following: L-aspartate, L-glutamine, L-asparagine, L-glutamate, ATP, AMP, and/or pyrophosphate, wherein a change in concentration for any of the above substances between steps (a) and (b) indicates that the test compound is a candidate for an antibiotic.

5. The method of claim 4 , wherein the Asparagine Synthase is a Magnaporthe Asparagine Synthase.

6. The method of claim 4 , wherein the Asparagine Synthase is SEQ ID NO: 3.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2004
From: PARADIGM GENETICS, INC.
To: ICORIA, INC.
Reel/Frame 015065/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2002
From: LO, SZE-CHUNG; MONTENEGRO-CHAMORRO, MARIA VICTORIA; FRANK, SHERYL; DARVEAUX, BLAISE; MAHANTY, SANJOY K.; HEINIGER, RYAN; SKALCHUNES, AMY; PAN, HUAQUIN; TARPEY, REX; SHUSTER, JEFFREY; TANZER, MATTHEW M.; HAMER, LISBETH; ADACHI, KIICHI; DEZWAAN, TODD M.
To: PARADIGM GENETICS, INC.
Reel/Frame 012677/0355 →
Continuity (1)
Related Publication 20030186837A1 · Oct 2, 2003